Rheuminations: Comparative Studies Needed for RA Biologics MedPage Today In one study, SWITCH-RA, patients given rituximab rather than a second TNF inhibitor had significantly better results on disease activity scores after 6 months. However, in a study comparing abatacept with additional anti-TNF treatment, similar results ... |
